Mechanistically, CagA hinders CD8+ T cell proliferation and anti-cancer responses by enhancing PD-L1 levels in exosomes from gastric cancer cells through p53 and miRNA-34a inhibition. The gene discussed is CD274; the disease is gastric cancer.